A citation-based method for searching scientific literature

Jorge A Marrero, Ziding Feng, Yinghui Wang, Mindie H Nguyen, Alex S Befeler, Lewis R Roberts, K Rajender Reddy, Denise Harnois, Josep M Llovet, Daniel Normolle, Jackie Dalhgren, David Chia, Anna S Lok, Paul D Wagner, Sudhir Srivastava, Myron Schwartz. Gastroenterology 2009
Times Cited: 424







List of co-cited articles
997 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
27

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
Anna S Lok, Richard K Sterling, James E Everhart, Elizabeth C Wright, John C Hoefs, Adrian M Di Bisceglie, Timothy R Morgan, Hae-Young Kim, William M Lee, Herbert L Bonkovsky,[...]. Gastroenterology 2010
367
26

AASLD guidelines for the treatment of hepatocellular carcinoma.
Julie K Heimbach, Laura M Kulik, Richard S Finn, Claude B Sirlin, Michael M Abecassis, Lewis R Roberts, Andrew X Zhu, M Hassan Murad, Jorge A Marrero. Hepatology 2018
25

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
Jorge A Marrero, Laura M Kulik, Claude B Sirlin, Andrew X Zhu, Richard S Finn, Michael M Abecassis, Lewis R Roberts, Julie K Heimbach. Hepatology 2018
23

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
Kristina Tzartzeva, Joseph Obi, Nicole E Rich, Neehar D Parikh, Jorge A Marrero, Adam Yopp, Akbar K Waljee, Amit G Singal. Gastroenterology 2018
263
20

Hepatocellular carcinoma.
Alejandro Forner, María Reig, Jordi Bruix. Lancet 2018
19

Management of hepatocellular carcinoma: an update.
Jordi Bruix, Morris Sherman. Hepatology 2011
17



Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
A Singal, M L Volk, A Waljee, R Salgia, P Higgins, M A M Rogers, J A Marrero. Aliment Pharmacol Ther 2009
463
14

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients.
Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Chiaki Kagebayashi, Shinji Satomura, Nora Schweitzer, Arndt Vogel, Michael P Manns, Julia Benckert,[...]. Clin Gastroenterol Hepatol 2016
108
13

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.
F Trevisani, P E D'Intino, A M Morselli-Labate, G Mazzella, E Accogli, P Caraceni, M Domenicali, S De Notariis, E Roda, M Bernardi. J Hepatol 2001
478
13

Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.
Jonggi Choi, Gi-Ae Kim, Seungbong Han, Woochang Lee, Sail Chun, Young-Suk Lim. Hepatology 2019
52
25

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.
Mariana Capurro, Ian R Wanless, Morris Sherman, Gerrit Deboer, Wen Shi, Eiji Miyoshi, Jorge Filmus. Gastroenterology 2003
615
13

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Qiujin Shen, Jia Fan, Xin-Rong Yang, Yexiong Tan, Weifeng Zhao, Yang Xu, Ning Wang, Yongdong Niu, Zheng Wu, Jian Zhou,[...]. Lancet Oncol 2012
259
12

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Sufen Shang, Amelie Plymoth, Shaokui Ge, Ziding Feng, Hugo R Rosen, Suleeporn Sangrajrang, Pierre Hainaut, Jorge A Marrero, Laura Beretta. Hepatology 2012
196
12

The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
Tomi Akinyemiju, Semaw Abera, Muktar Ahmed, Noore Alam, Mulubirhan Assefa Alemayohu, Christine Allen, Rajaa Al-Raddadi, Nelson Alvis-Guzman, Yaw Amoako, Al Artaman,[...]. JAMA Oncol 2017
670
12

Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Nicolas Poté, François Cauchy, Miguel Albuquerque, Hélène Voitot, Jacques Belghiti, Laurent Castera, Hervé Puy, Pierre Bedossa, Valérie Paradis. J Hepatol 2015
133
12

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
V Mazzaferro, E Regalia, R Doci, S Andreola, A Pulvirenti, F Bozzetti, F Montalto, M Ammatuna, A Morabito, L Gennari. N Engl J Med 1996
12

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
11

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Masao Omata, Ann-Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang-Hyub Han, Yoghesh K Chawla, Shuichiro Shiina,[...]. Hepatol Int 2017
750
11

An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
Omair Atiq, Jasmin Tiro, Adam C Yopp, Adam Muffler, Jorge A Marrero, Neehar D Parikh, Caitlin Murphy, Katharine McCallister, Amit G Singal. Hepatology 2017
104
11

Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
Rui-Hua Xu, Wei Wei, Michal Krawczyk, Wenqiu Wang, Huiyan Luo, Ken Flagg, Shaohua Yi, William Shi, Qingli Quan, Kang Li,[...]. Nat Mater 2017
296
10

Randomized controlled trial of screening for hepatocellular carcinoma.
Bo-Heng Zhang, Bing-Hui Yang, Zhao-You Tang. J Cancer Res Clin Oncol 2004
890
10

The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers.
Philip J Johnson, Sarah J Pirrie, Trevor F Cox, Sarah Berhane, Mabel Teng, Daniel Palmer, Janet Morse, Diana Hull, Gillian Patman, Chiaki Kagebayashi,[...]. Cancer Epidemiol Biomarkers Prev 2014
99
10

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Jorge A Marrero, Patrick R Romano, Olga Nikolaeva, Laura Steel, Anand Mehta, Claus J Fimmel, Mary Ann Comunale, Anthony D'Amelio, Anna S Lok, Timothy M Block. J Hepatol 2005
246
10

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Adrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, James E Everhart, Jules L Dienstag, Herbert L Bonkovsky, Elizabeth C Wright, Gregory T Everson, Karen L Lindsay, Anna S F Lok,[...]. J Hepatol 2005
207
10

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Shinichiro Nakamura, Kazuhiro Nouso, Kohsaku Sakaguchi, Yoichi M Ito, Yasuo Ohashi, Yoshiyuki Kobayashi, Nobuyuki Toshikuni, Hironori Tanaka, Yasuhiro Miyake, Eiji Matsumoto,[...]. Am J Gastroenterol 2006
111
9


Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Jun Ji, Hao Wang, Yan Li, Lei Zheng, Yuepeng Yin, Zhenzhen Zou, Feiguo Zhou, Weiping Zhou, Feng Shen, Chunfang Gao. PLoS One 2016
42
21

AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.
D Li, T Mallory, S Satomura. Clin Chim Acta 2001
188
9

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.
Michael L Volk, Jose C Hernandez, Grace L Su, Anna S Lok, Jorge A Marrero. Cancer Biomark 2007
95
9

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
Jorge A Marrero, Grace L Su, Wei Wei, Dawn Emick, Hari S Conjeevaram, Robert J Fontana, Anna S Lok. Hepatology 2003
285
9

Hepatocellular Carcinoma.
Augusto Villanueva. N Engl J Med 2019
9

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
Yilei Mao, Huayu Yang, Haifeng Xu, Xin Lu, Xinting Sang, Shunda Du, Haitao Zhao, Wang Chen, Yiyao Xu, Tianyi Chi,[...]. Gut 2010
154
8

Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?
Amit G Singal, Mahendra Nehra, Beverley Adams-Huet, Adam C Yopp, Jasmin A Tiro, Jorge A Marrero, Anna S Lok, William M Lee. Am J Gastroenterol 2013
142
8

Hepatocellular carcinoma.
Hashem B El-Serag. N Engl J Med 2011
8

Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Tae Seop Lim, Do Young Kim, Kwang-Hyub Han, Hyon-Suk Kim, Seung Hwan Shin, Kyu Sik Jung, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn. Scand J Gastroenterol 2016
45
17

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
952
8


Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.
Amit G Singal, Hari S Conjeevaram, Michael L Volk, Sherry Fu, Robert J Fontana, Fred Askari, Grace L Su, Anna S Lok, Jorge A Marrero. Cancer Epidemiol Biomarkers Prev 2012
164
8

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Francisco A Durazo, Lawrence M Blatt, William G Corey, Jiing-Huey Lin, Steven Han, Sammy Saab, Ronald W Busuttil, Myron J Tong. J Gastroenterol Hepatol 2008
121
8

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang,[...]. Lancet Oncol 2009
8

Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
8

MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
So Yeon Kim, Jihyun An, Young-Suk Lim, Seungbong Han, Ji-Young Lee, Jae Ho Byun, Hyung Jin Won, So Jung Lee, Han Chu Lee, Yung Sang Lee. JAMA Oncol 2017
122
7

Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
Ju Dong Yang, Jianliang Dai, Amit G Singal, Purva Gopal, Benyam D Addissie, Mindie H Nguyen, Alex S Befeler, K Rajender Reddy, Myron Schwartz, Denise M Harnois,[...]. Cancer Epidemiol Biomarkers Prev 2017
26
26

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.
O Simmons, D T Fetzer, T Yokoo, J A Marrero, A Yopp, Y Kono, N D Parikh, T Browning, A G Singal. Aliment Pharmacol Ther 2017
122
7

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities.
Jean-Claude Trinchet, Cendrine Chaffaut, Valérie Bourcier, Françoise Degos, Jean Henrion, Hélène Fontaine, Dominique Roulot, Ariane Mallat, Sophie Hillaire, Paul Cales,[...]. Hepatology 2011
216
7

Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study.
C Pocha, E Dieperink, K A McMaken, A Knott, P Thuras, S B Ho. Aliment Pharmacol Ther 2013
74
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.